Today: 9 Fevereiro 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 160

BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin (BMRN) Stock News Today: Amicus Acquisition Fallout, BMN 349 Cut, and Fresh Wall Street Price Targets (Dec. 22, 2025)

BioMarin shares fell 3.5% to $58.98 on Dec. 22 after analysts weighed in on its $4.8 billion Amicus Therapeutics acquisition and the company confirmed it ended development of BMN 349. Truist Securities raised its price target to $100, citing strategic fit, while other analysts questioned the deal’s impact on growth and balance sheet risk.
22 Dezembro 2025
··
Costco Stock (COST) After Hours Today, Dec. 22, 2025: Key Headlines, Analyst Calls, and What to Watch Before Tuesday’s Open

Costco Stock (COST) After Hours Today, Dec. 22, 2025: Key Headlines, Analyst Calls, and What to Watch Before Tuesday’s Open

Costco shares closed Monday at $850, down 0.66%, and slipped to $849.32 in late after-hours trading. The stock underperformed broader U.S. indexes, which rose as the VIX hit a year low. Guggenheim reiterated a Neutral rating, citing Costco’s high valuation and softening membership metrics. COST has fallen about 11% over six months, while the S&P 500 gained 12%.
23 Dezembro 2025
·
Warner Bros. Discovery (WBD) Stock After Hours Today (Dec. 22, 2025): Paramount’s Ellison-Backed $30 Bid vs. Netflix Deal — What to Know Before Tuesday’s Open

Warner Bros. Discovery (WBD) Stock After Hours Today (Dec. 22, 2025): Paramount’s Ellison-Backed $30 Bid vs. Netflix Deal — What to Know Before Tuesday’s Open

Warner Bros. Discovery shares rose 3.53% to $28.75 Monday after confirming receipt of an amended all-cash takeover bid from Paramount Skydance, backed by Larry Ellison’s $40.4 billion personal guarantee. The board said it still supports a rival Netflix deal and urged shareholders to take no action for now.
23 Dezembro 2025
···
Lululemon Stock After Hours Today (Dec. 22, 2025): LULU Holds Near $212—What to Know Before the Market Opens Dec. 23

Lululemon Stock After Hours Today (Dec. 22, 2025): LULU Holds Near $212—What to Know Before the Market Opens Dec. 23

Lululemon shares closed Monday up 1.39% at $212.37, holding steady in after-hours trading. The stock remains about 50% below its 52-week high. Investors are watching a CEO transition, with Calvin McDonald set to step down and activist Elliott Management building a $1 billion stake. Trading volume was slightly below average.
23 Dezembro 2025
··
FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

The FDA approved Novo Nordisk’s once-daily Wegovy pill (oral semaglutide 25 mg) for chronic weight management and reducing cardiovascular risk in adults with obesity or overweight on December 22, 2025. The company plans a U.S. launch in January 2026 at $149 per month for eligible patients. Clinical trials showed average weight loss of 13.6% to 16.6% depending on adherence.
23 Dezembro 2025
··
Glencore plc Stock News and Forecast (GLEN.L): Share Price Holds Near 390p as Copper, Cobalt and Deal-Making Shape the 2026 Outlook

Glencore plc Stock News and Forecast (GLEN.L): Share Price Holds Near 390p as Copper, Cobalt and Deal-Making Shape the 2026 Outlook

Glencore shares traded at 389p in London on 23 December, near their 52-week high of 398.80p. The company agreed to acquire a majority stake in Dutch fuel supplier FincoEnergies, aiming to expand in Northwest Europe’s fuel and biofuels markets. The deal awaits EU antitrust approval and is expected to close in Q2 2026. Glencore also outlined plans to boost copper production to 1 million tonnes by 2028.
23 Dezembro 2025
···
Novo Nordisk (NVO) Stock Jumps After FDA Approves Wegovy Pill: Today’s News, Analyst Forecasts, and 2026 Catalysts (23 December 2025)

Novo Nordisk (NVO) Stock Jumps After FDA Approves Wegovy Pill: Today’s News, Analyst Forecasts, and 2026 Catalysts (23 December 2025)

The FDA approved Novo Nordisk’s oral Wegovy pill for chronic weight management in the U.S., marking the first oral GLP-1 agonist cleared for this use. Shares jumped on the news, lifting European healthcare stocks. The company reported 16.6% mean weight loss in trials when taken as prescribed. Novo plans to launch the pill in the U.S. in early January 2026.
23 Dezembro 2025
···
IonQ Stock (IONQ) Surges as Wall Street Turns Bullish: Today’s News, Analyst Price Targets, and the 2026 Outlook (Dec. 23, 2025)

IonQ Stock (IONQ) Surges as Wall Street Turns Bullish: Today’s News, Analyst Price Targets, and the 2026 Outlook (Dec. 23, 2025)

IonQ shares jumped 11.1% to close at $53.86 on Dec. 22, with trading volume near 28.6 million. The surge followed a series of positive analyst initiations, including Jefferies (Buy, $100 target), Wedbush (Outperform, $60), and Mizuho (Outperform, $90). Major firms like JPMorgan and Evercore ISI also launched coverage, fueling renewed interest and volatility in quantum stocks.
23 Dezembro 2025
·
SELLAS Life Sciences (SLS) Stock Update: ASH 2025 Data, REGAL Trial Countdown, Analyst Targets, and Key Risks (Dec. 23, 2025)

SELLAS Life Sciences (SLS) Stock Update: ASH 2025 Data, REGAL Trial Countdown, Analyst Targets, and Key Risks (Dec. 23, 2025)

SELLAS Life Sciences shares surged on heavy volume to $2.64 after the company presented updated Phase 2 data for SLS009 in relapsed/refractory AML at ASH 2025. The study showed a 46% overall response rate among 35 patients, with no dose-limiting toxicities reported. Final analysis of the Phase 3 REGAL trial for galinpepimut-S is expected by year-end.
23 Dezembro 2025
·
Tesla Stock (TSLA) Today: Dec. 23, 2025 News, Forecasts, and Analysis as Shares Hover Near $500

Tesla Stock (TSLA) Today: Dec. 23, 2025 News, Forecasts, and Analysis as Shares Hover Near $500

Tesla shares closed at $488.73 Monday after touching $498.83, nearing the $500 mark amid heavy trading. The stock dipped to about $487.49 in early premarket Tuesday. Investors are focused on Tesla’s robotaxi developments and Q4 delivery results due January 2. Recent gains follow optimism over autonomy, despite concerns about near-term delivery forecasts and increased competition.
23 Dezembro 2025
··
Broadcom Stock (AVGO) on Dec. 23, 2025: AI Demand Stays Red-Hot, but Margin Pressure, Insider Moves, and Valuation Fears Keep Investors Selective

Broadcom Stock (AVGO) on Dec. 23, 2025: AI Demand Stays Red-Hot, but Margin Pressure, Insider Moves, and Valuation Fears Keep Investors Selective

Broadcom reported fourth-quarter revenue of $18.015 billion, up 28% from a year ago, and guided to $19.1 billion for Q1 FY2026. Shares traded near $341 on December 23 after a volatile month, as investors weighed record AI-driven growth against concerns over lower margins from custom AI chips. The company raised its quarterly dividend to $0.65 per share. AI semiconductor revenue jumped 74% year over year in Q4.
23 Dezembro 2025
·
Snap Stock (SNAP) News Today: AI Video Tools, Legal Headlines, Analyst Forecasts, and What Investors Are Watching on Dec. 23, 2025

Snap Stock (SNAP) News Today: AI Video Tools, Legal Headlines, Analyst Forecasts, and What Investors Are Watching on Dec. 23, 2025

Snap Inc. shares fell 1.57% to $7.815 on Dec. 23, 2025, after surging nearly 5% the previous session. Monday’s rally followed the launch of an AI video tool for Lens+ subscribers and news that an investor dropped a lawsuit over alleged ad-platform issues. The stock remains about 40% below its 52-week high of $13.28.
23 Dezembro 2025
··
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly shares hovered near record highs Tuesday after the FDA approved Novo Nordisk’s first oral Wegovy pill, intensifying rivalry in the obesity drug market. LLY traded around $1,077 as investors weighed Novo’s launch against Lilly’s own oral candidate, orforglipron, which could reach the market in 2026. Both firms have signaled lower pricing for new pills as competition heats up.
23 Dezembro 2025
···
Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa reported U.S. holiday retail spending rose 4.2% year over year, with e-commerce sales up 7.8% and in-store purchases making up 73% of volume. As of early afternoon Dec. 23, Visa shares traded near $354, up 0.5%. The company’s results trailed its earlier forecast but outpaced Mastercard’s 3.9% growth. Investors are also watching Visa’s moves in stablecoin settlement and AI-driven commerce.
23 Dezembro 2025
··
Globalstar (GSAT) Stock News and Forecasts on Dec. 23, 2025: Insider Selling, Band n53 Momentum, and Analyst Price Targets

Globalstar (GSAT) Stock News and Forecasts on Dec. 23, 2025: Insider Selling, Band n53 Momentum, and Analyst Price Targets

Globalstar shares fell 4.3% to around $63.75 on December 23 after insider sale disclosures by CFO Rebecca Clary and General Counsel L. Barbee IV Ponder. The stock swung between $61.76 and $66.60 intraday. The company also announced a private 5G drone connectivity trial with Skydio using its Band n53 spectrum. Analyst coverage described the risk/reward as “mostly balanced” following recent gains.
23 Dezembro 2025
··
Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc (FRMI) Stock Today, Dec. 23, 2025: Tenant Funding Deal Fallout, Amazon Rumor Denial, and What Analysts Forecast Next

Fermi Inc. shares fell into the mid-$8 range on December 23 after a prospective anchor tenant terminated a $150 million construction-funding agreement for its Texas Project Matador campus. Business Insider reported Amazon was the tenant, but Fermi denied this to Reuters. No funds had been drawn under the agreement. Fermi says lease negotiations with the tenant are ongoing.
23 Dezembro 2025
··
Target Stock News Today: TGT Slips on Dec. 23, 2025 as Holiday Sales Data, App Outage, and Wall Street Forecasts Shape 2026 Outlook

Target Stock News Today: TGT Slips on Dec. 23, 2025 as Holiday Sales Data, App Outage, and Wall Street Forecasts Shape 2026 Outlook

Target shares fell about 1% to $94.23 Tuesday after Wolfe Research cut its Q4 same-store sales estimate, citing a recent digital outage and Walmart’s continued outperformance. The outage last week disrupted Target’s app, website, and some gift card processing during the holiday rush. Options activity showed moderately bearish sentiment. U.S. holiday retail sales rose roughly 4% year over year, according to Visa and Mastercard.
23 Dezembro 2025
··
1 … 158 159 160 161 162 … 177
Go toTop